Company / Shares Outstanding
Adaptimmune Therapeutics PLC Shares Outstanding History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
1.4B
FY2024
5-year range
631.0M / 1.4B
FY2020-FY2024
Trend
+38.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from 928547934.00 to 1363008102.00 over the past 2 years.
Based on SEC 10-K filings.
1363008102.00 in FY2024 with a 5-year CAGR of +16.8%.
Increased from 928547934.00 to 1363008102.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +13.6%
- 5-Year CAGR
- +16.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, shares outstanding increased 38.1% year-over-year.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 1.4B | +38.1% |
| FY2023 | 987.1M | +6.3% |
| FY2022 | 928.5M | -0.0% |
| FY2021 | 928.8M | +47.2% |
| FY2020 | 631.0M | +0.6% |
| FY2019 | 627.5M | +11.6% |
| FY2018 | 562.1M | +32.3% |
| FY2017 | 424.8M | +0.0% |
| FY2016 | 424.7M | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026